The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Travel, Accommodations, Expenses - Lotus Pharmaceutical Co Ltd.
Neoadjuvant (neoadj) osimertinib (osi) ± chemotherapy (CT) vs CT alone in resectable (R) epidermal growth factor receptor-mutated (EGFRm) NSCLC: NeoADAURA.
 
Jamie Chaft
Consulting or Advisory Role - Arcus Biosciences; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; Guardant Health; Janssen Oncology; Lilly; Merck; Sanofi/Regeneron
Research Funding - AstraZeneca/MedImmune (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis
(OPTIONAL) Uncompensated Relationships - AstraZeneca
 
Walter Weder
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Jianxing He
No Relationships to Disclose
 
Keneng Chen
No Relationships to Disclose
 
Maximilian Hochmair
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Lilly; Roche; Takeda
Speakers' Bureau - Lilly; MSD Oncology; Novartis; Roche
 
Jin-Yuan Shih
Honoraria - ABBVIE/ABBOTT; ACT Genomics; ACTgenomic; Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; CStone Pharmaceuticals; Daiichi-Sankyo; GlaxoSmithKline,; Guardant Health; Illumina; Janssen; Lilly; Lotus; Merck KGaA; Merck Sharp & Dohme; Novartis; Ono Pharmaceutical; Orient EuroPharma; Pfizer; Roche; Synmosa Biopharma; Takeda; TSH Biopharm; TTY Biopharm; Welgene Biotech; Zuellig Pharma
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen Oncology; Merck Sharp & Dohme; Pfizer; Roche; Takeda; Zuellig Pharma
Research Funding - Roche
Travel, Accommodations, Expenses - AstraZeneca; Chugai Pharma; Pfizer; Roche
 
Sung Yong Lee
No Relationships to Disclose
 
Kang-Yun Lee
No Relationships to Disclose
 
Nguyen Nhung
No Relationships to Disclose
 
Somcharoen Saeteng
Honoraria - AstraZeneca (Thailand); Johnson & Johnson (Thailand); Medtronic (Thailand)
Consulting or Advisory Role - AstraZeneca (Thailand); Roche (Thailand)
Speakers' Bureau - AstraZeneca Canada; Johnson & Johnson; Medtronic; Merck Sharp & Dohme; Roche
Research Funding - AstraZeneca; Novartis; Roche
Travel, Accommodations, Expenses - AstraZeneca (Thailand); Johnson & Johnson (Thailand); Medtronic (Thailand); Roche (Thailand)
 
Carlos Andrade Teixeira
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Janssen; Merck
Travel, Accommodations, Expenses - Daiichi Sankyo; Janssen; Merck
 
Carles Escriu
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Pfizer; Regeneron
Speakers' Bureau - AstraZeneca; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Janssen; Roche
 
Alex Martinez-Marti
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; janssen; Merck Sharp & Dohme; MSD Oncology; Pfizer; Roche
Speakers' Bureau - Amgen; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen Oncology; Merck Sharp & Dohme; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche
 
Collin Blakely
Honoraria - Aptitude Health; Axiom Healthcare Strategies; OncLive/MJH Life Sciences
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb/Pfizer; Gilead Sciences; Janssen Oncology; Kura Oncology (I); Rigel (I); SERVIER (I); Takeda
Research Funding - AstraZeneca (Inst); Cellectis (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); Spectrum Pharmaceuticals (Inst); Takeda (Inst); Verastem (Inst)
 
Yasushi Yatabe
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Chugai Pharma; Daiichi Sankyo/UCB Japan; MSD K.K
Speakers' Bureau - Abbvie; Amgen; AstraZeneca; Chugai Pharma; Daiichi Sankyo/Astra Zeneca; MSD K.K
Research Funding - Konica Minolta; Merck; Thermo Fisher Scientific
 
Sanja Dacic
Honoraria - AstraZeneca; Genentech/Roche
Consulting or Advisory Role - AstraZeneca
(OPTIONAL) Uncompensated Relationships - Genentech
 
Xiangning Huang
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Yuri Rukazenkov
No Relationships to Disclose
 
Anupriya Dayal
No Relationships to Disclose
 
Masahiro Tsuboi
Honoraria - Amgen KK; AstraZeneca Japan; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi-Sankyo; Johnson & Johnson; Lilly Japan; Medtronic; MSD K.K; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca; AstraZeneca Japan; Chugai Pharma; MiRXES; MSD; Novartis
Research Funding - AstraZeneca Japan (Inst); Bristol-Myers Squibb KK (Inst); Johnson & Johnson/Eticon (Inst); Merck (Inst); MiRXES (Inst); Novartis (Inst); Ono Pharmaceutical (Inst)